Bendamax (Bendamustine Vials) 100mg

Bendamax (Bendamustine 100mg) is an injectable chemotherapy medication used to treat certain cancers. This vial formulation is stored at room temperature and manufactured by GLS Pharma in India. Commonly prescribed for blood cancers, it belongs to the alkylating agent class.

Strength

100mg

Pack Size

Storage

Ambient

Manufacturer / TM Owner

GLS Pharma

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Bendamax is primarily used to treat forms of blood cancer such as chronic lymphocytic leukemia and non-Hodgkin lymphoma. It may also be prescribed for other cancer types as determined by a healthcare professional. Patients often ask, 'what is Bendamax used for' to understand its role in cancer treatment plans. Always consult a doctor for personalized treatment guidance.

Side Effects

Bendamax works by interfering with cancer cell growth and division, helping to reduce tumor size. Patients may notice effects such as improved energy levels or reduced symptoms related to their condition over time. Individual responses vary based on treatment protocols and health status.

Precautions & Warnings

Store Bendamax vials at room temperature away from moisture and heat. Keep out of reach of children and pets. Handle with care to avoid accidental exposure; use gloves and dispose of materials properly. Always follow healthcare provider instructions for safe handling and administration.

Avoid Interactions

Bendamax may interact with other medications, including CYP1A2 inhibitors and live vaccines. Avoid alcohol and consult your doctor before combining with herbal supplements or over-the-counter drugs. Certain vaccines should not be administered during treatment. Discuss all current medications with your healthcare team.

Frequently Asked Questions

Bendamax is used to treat certain blood cancers like chronic lymphocytic leukemia and non-Hodgkin lymphoma.

Bendamax is given as an intravenous infusion by a healthcare professional in a clinical setting.

Common effects may include nausea, fatigue, or low blood cell counts; discuss any concerns with your doctor.

Yes, store Bendamax vials at room temperature in a dry place away from children and pets.

Bendamax may interact with CYP1A2 inhibitors and live vaccines; always inform your doctor of all medications.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.